Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions

View through CrossRef
ABSTRACT ( R,S )-ketamine (ketamine) has rapid and sustained antidepressant (AD) efficacy at sub-anesthetic doses in depressed patients. A metabolite of ketamine, including ( 2R,6R )-hydroxynorketamine (( 6 )-HNKs) has been reported to exert antidepressant actions in rodent model of anxiety/depression. To further understand the specific role of ketamine’s metabolism in the AD actions of the drug, we evaluated the effects of inhibiting hepatic cytochrome P450 enzymes on AD responses. We assessed whether pre-treatment with fluconazole (10 and 20 mg/kg, i.p.) 1 hour prior to ketamine or HNKs (10 mg/kg, i.p.) administration would alter behavioral and neurochemical actions of the drugs in male BALB/cJ mice with a highly anxious phenotype. Extracellular microdialysate levels of glutamate and GABA (Glu ext , GABA ext ) were also measured in the medial prefrontal cortex (mPFC). Pre-treatment with fluconazole altered the pharmacokinetic profile of ketamine, by increasing both plasma and brain levels of ketamine and ( R , S )-norketamine, while robustly reducing those of ( 6 )-HNKs. At 24 hours post-injection (t24h), fluconazole prevented the sustained AD-like response of ketamine responses in the forced swim test and splash test, as well as the enhanced cortical GABA levels produced by ketamine. A single ( 2R,6R )-HNK administration selectively rescued the antidepressant-like activity of ketamine in mice pretreated with fluconazole within 24 hours of treatment. Overall, these findings are consistent with an essential role of ( 6 )-HNK in mediating the sustained antidepressant-like effects of ketamine and suggest potential interactions between pharmacological CYPIs and ketamine during antidepressant treatment in patients.
Title: Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions
Description:
ABSTRACT ( R,S )-ketamine (ketamine) has rapid and sustained antidepressant (AD) efficacy at sub-anesthetic doses in depressed patients.
A metabolite of ketamine, including ( 2R,6R )-hydroxynorketamine (( 6 )-HNKs) has been reported to exert antidepressant actions in rodent model of anxiety/depression.
To further understand the specific role of ketamine’s metabolism in the AD actions of the drug, we evaluated the effects of inhibiting hepatic cytochrome P450 enzymes on AD responses.
We assessed whether pre-treatment with fluconazole (10 and 20 mg/kg, i.
p.
) 1 hour prior to ketamine or HNKs (10 mg/kg, i.
p.
) administration would alter behavioral and neurochemical actions of the drugs in male BALB/cJ mice with a highly anxious phenotype.
Extracellular microdialysate levels of glutamate and GABA (Glu ext , GABA ext ) were also measured in the medial prefrontal cortex (mPFC).
Pre-treatment with fluconazole altered the pharmacokinetic profile of ketamine, by increasing both plasma and brain levels of ketamine and ( R , S )-norketamine, while robustly reducing those of ( 6 )-HNKs.
At 24 hours post-injection (t24h), fluconazole prevented the sustained AD-like response of ketamine responses in the forced swim test and splash test, as well as the enhanced cortical GABA levels produced by ketamine.
A single ( 2R,6R )-HNK administration selectively rescued the antidepressant-like activity of ketamine in mice pretreated with fluconazole within 24 hours of treatment.
Overall, these findings are consistent with an essential role of ( 6 )-HNK in mediating the sustained antidepressant-like effects of ketamine and suggest potential interactions between pharmacological CYPIs and ketamine during antidepressant treatment in patients.

Related Results

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
AbstractThe discovery of robust antidepressant actions exerted by the N-methyl-D-aspartate receptor (NMDAR) antagonist (R,S)-ketamine has been a crucial breakthrough in mood disord...
Synthesis of Ketamine Derivatives by Mannich Reactions
Synthesis of Ketamine Derivatives by Mannich Reactions
Arylcyclohexylamine Ketamine (HCL) has played an important role in Veterinary and Human Medicine as safe and reliable anesthetic agent but asit produces dysphoria several new deriv...
The cytochrome P450 reductase contributes to normal cardiovascular function
The cytochrome P450 reductase contributes to normal cardiovascular function
Cytochrome P450 enzymes are a large superfamily of membrane-bound heme-containing monooxygenases. They are essential for the oxidative metabolism of endogenous substrates such as s...
Ketamine Produces a Long-Lasting Enhancement of CA1 Neuron Excitability
Ketamine Produces a Long-Lasting Enhancement of CA1 Neuron Excitability
Abstract Background Ketamine is a clinical anaesthetic and a fast-acting, long-lasting antidepressant. Ketamine is known for it...
Do cytochrome P450 2C9 pathways contribute to the cerebrovascular response to small muscle exercise?
Do cytochrome P450 2C9 pathways contribute to the cerebrovascular response to small muscle exercise?
Cytochrome P450 2C9 (CYP450) contributes to regulation of cerebral blood flow in animal models, however, the involvement of CYP450 in human cerebrovascular control is under researc...
Lasting s-ketamine block of spreading depolarizations in subarachnoid hemorrhage: a retrospective cohort study
Lasting s-ketamine block of spreading depolarizations in subarachnoid hemorrhage: a retrospective cohort study
Abstract Objective Spreading depolarizations (SD) are characterized by breakdown of transmembrane ion gradients and excitotoxicity. Experimentally, ...
Prediction of Prophylactic Response to Lithium in Bipolar Disorder Using Acute Antidepressant Non-Response to Ketamine: A Scoping Review
Prediction of Prophylactic Response to Lithium in Bipolar Disorder Using Acute Antidepressant Non-Response to Ketamine: A Scoping Review
Lithium remains the first choice for long-term prophylaxis of mood episodes in bipolar disorder (BD), but only 30% of patients will respond, and there is no reliable method by whic...

Back to Top